To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
Human iPSC with HiBit-tagged Parkin*
Human iPS Cell
Human iPSC line with HiBiT tag on the Parkin protein and inducible LgBiT expression for live cell imaging and quantitation. Cell line was developed and kindly shared by Dr. Tom Durcan at McGill University through the MJFF Sponsored Tools Program.
Human iPSC with HiBit-tagged SNCA*
Human iPS Cell
Human iPSC line with HiBiT tag on the alpha-synuclein protein and inducible LgBiT expression for live cell imaging and quantitation. Cell line was developed and kindly shared by Dr. Tom Durcan at McGill University through the MJFF Sponsored Tools Program.
Human iPSC with HiBit-tagged VPS13C*
Human iPS Cell
Human iPSC line with HiBiT tag on the VPS13C protein and inducible LgBiT expression for live cell imaging and quantitation. Cell line was developed and kindly shared by Dr. Tom Durcan at McGill University through the MJFF Sponsored Tools Program.
Human iPSC with HiBit-tagged VPS35*
Human iPS Cell
Human iPSC line with HiBiT tag on the VPS35 protein and inducible LgBiT expression for live cell imaging and quantitation. Cell line was developed and kindly shared by Dr. Tom Durcan at McGill University through the MJFF Sponsored Tools Program.
LRRK2 iPSC Cell Line Collection*
Human iPS Cell
Human iPSC lines focused on pathogenic LRRK2 gene variants made available in collaboration with Dr. Birgitt Schuele at Stanford University School of Medicine. The series includes homozygous and heterozygous LRRK2 p.G2019S mutants, isogenic derivatives generated by Zinc Finger Nuclease (ZFN) editing (biallelic correction, knockout, and unedited controls), healthy controls, and a unique double-mutant line combining LRRK2 p.G2019S with a PARKIN (PRKN) exon 5 copy-number variation.
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic